The immunostimulatory activity of 3-(p-chlorophenyl)-2,3-dihydro-3-hydroxythiazole [3, 2-α]-benzimidazole-2-acetic acid (NSC 208828)
- 15 April 1978
- journal article
- research article
- Published by Elsevier
- Vol. 14 (4) , 393-400
- https://doi.org/10.1016/0014-2964(78)90210-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- IMMUNOCHEMOTHERAPY WITH CORYNEBACTERIUM PARVUM IN DISSEMINATED CANCER*Annals of the New York Academy of Sciences, 1976
- Anti-tumour and anti-metastatic activity of 3-(P-Chlorophenyl)-2,3-Dihydro-3-Hydroxythiazolo [3,2-a]-Benzimidazole-2-acetic acid (WY-13,876)British Journal of Cancer, 1976
- Human toxicology of BCG applied in cancer immunotherapyCancer Immunology, Immunotherapy, 1976
- Effect of Corynebacterium parvum on cellular and humoral antitumoral immune effector mechanismsPublished by Elsevier ,1976
- Characterization of the immunostimulants levamisole and tetramisolePublished by Elsevier ,1975
- Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: Studies on cell-mediated immunity and humoral antibody responsePublished by Elsevier ,1975
- Complications of BCG Immunotherapy in Patients with CancerNew England Journal of Medicine, 1973
- Effects of BCG on various facets of the immune response against polyoma tumors in ratsInternational Journal of Cancer, 1973
- Facilitation of Rat Mammary Tumour Growth by BCGNature, 1970
- A LYMPH NODE WEIGHT ASSAY FOR THE GRAFTVERSUS- HOST ACTIVITY OF RAT LYMPHOID CELLSTransplantation, 1970